Analysis showed that UBE2S expression was positively associated with PTEN-mutation and EGFR amplification and negatively associated to IDH1-mutation and co-deletion of 1p19q in whole grade glioma (Figure 3). This evidence concerns the gene UBE2S and central nervous system cancer.